Patrick J. Christmas - Net Worth and Insider Trading

Patrick J. Christmas Net Worth

The estimated net worth of Patrick J. Christmas is at least $245,089 dollars as of 2024-05-29. Patrick J. Christmas is the Chief Legal Officer of Regenxbio Inc and owns about 16,372 shares of Regenxbio Inc (RGNX) stock worth over $245,089. Details can be seen in Patrick J. Christmas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Patrick J. Christmas has not made any transactions after 2021-02-12 and currently still holds the listed stock(s).

Transaction Summary of Patrick J. Christmas

Patrick J. Christmas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick J. Christmas owns 1 companies in total, including Regenxbio Inc (RGNX) .

Click here to see the complete history of Patrick J. Christmas’s form 4 insider trades.

Insider Ownership Summary of Patrick J. Christmas

Ticker	Comapny	Transaction Date	Type of Owner
RGNX	Regenxbio Inc	2021-02-12	Senior VP & General Counsel

Patrick J. Christmas Latest Holdings Summary

Patrick J. Christmas currently owns a total of 1 stock. Patrick J. Christmas owns 16,372 shares of Regenxbio Inc (RGNX) as of February 12, 2021, with a value of $245,089.

Latest Holdings of Patrick J. Christmas

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
RGNX	Regenxbio Inc	2021-02-12	16,372	14.97	245,089

Holding Weightings of Patrick J. Christmas

Patrick J. Christmas Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick J. Christmas has made a total of 7 transactions in Regenxbio Inc (RGNX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Regenxbio Inc is the sale of 4,701 shares on February 12, 2021, which brought Patrick J. Christmas around $230,725.

Insider Trading History of Patrick J. Christmas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick J. Christmas Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Patrick J. Christmas Ownership Network

Ownership Network List of Patrick J. Christmas

No Data

Ownership Network Relation of Patrick J. Christmas

Patrick J. Christmas Owned Company Details

What does Regenxbio Inc do?

Who are the key executives at Regenxbio Inc?

Patrick J. Christmas is the Senior VP & General Counsel of Regenxbio Inc. Other key executives at Regenxbio Inc include director & See Remarks Kenneth T. Mills , Chief Medical Officer Steve Pakola , and See Remarks Vittal Vasista .

Regenxbio Inc (RGNX) Insider Trades Summary

Over the past 18 months, Patrick J. Christmas made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 150,000 shares made by Kenneth T. Mills , and a net sale of 12,878 shares made by Steve Pakola .

In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 162,878 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 162,878 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regenxbio Inc Insider Transactions

No Available Data

Patrick J. Christmas Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick J. Christmas. You might contact Patrick J. Christmas via mailing address: C/o Regenxbio Inc., 9804 Medical Center Drive, Rockville Md 20850.

Discussions on Patrick J. Christmas

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.